Evidence map›Paper›PMID 42575776›Full record

ArticleProtein expression and purification2027

Corrigendum to "Purification and characterization of full-length monomeric TEC family kinase, ITK" [Protein Expr. Purif. 229 (2025) 106682].

Udumbara M Rathnayake, Junya Wada, Vanessa E Wall, Jane Jones, Lisa M Jenkins, Amy H Andreotti, Lawrence E Samelson

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein expression and purification, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Udumbara M RathnayakeLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Junya WadaLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Vanessa E WallProtein Expression Laboratory and RAS Reagents Core, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Jane JonesProtein Expression Laboratory and RAS Reagents Core, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Lisa M JenkinsLaboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Amy H AndreottiRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, 50014, USA.
Lawrence E SamelsonLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Electronic address: samelsonl@mail.nih.gov.

Funding

BIOCHEMICAL BASIS OF T CELL ACTIVATIONZ01BC010304 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SAMELSON, LAWRENCE E · 1999 to 2008
$2.6M
Intramural NIH HHS Z01 BC010304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42575776
PMCPMC13643485

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.